Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pramipexole, sold under the brand Mirapex among others, is a medication used to treat Parkinson's disease and restless legs syndrome. In Parkinson's disease it may be used alone or together with levodopa. It is taken by mouth. Pramipexole is a dopamine agonist of the non-ergoline class.
The analysis highlights Applications and Research as prominent areas in the source structure around Pramipexole.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Pramipexole shows recurring relationship patterns in the source. For example, Pramipexole → Another, CJ-1037, CJ-1638, CJ-1639, CJ-998, D-264, D-440, D-512, Derivatives Another extracted example is Pramipexole → IL-12, IL-18, IL-1β, IL-6, IL-8, NF-κB, Parkinson's, TNF-α. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
dopamine parkinson's treatment disease may used shown effects also restless syndrome drug depression via medication agonist side dopaminergic release d3
TTTA extracted 73 structured relationships around Pramipexole. Examples in this analysis include Pramipexole → 3D model (JSmol) → Interactive image and Pramipexole → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pramipexole | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pramipexole | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Pramipexole | ATC code | N04BC05 (WHO) | 1.00 | infobox |
| Pramipexole | Bioavailability | >90% | 1.00 | infobox |
| Pramipexole | CAS Number | 104632-26-0 Y | 1.00 | infobox |
| Pramipexole | ChEBI | CHEBI:8356 Y | 1.00 | infobox |
| Pramipexole | ChEMBL | ChEMBL301265 Y | 1.00 | infobox |
| Pramipexole | ChemSpider | 106770 Y | 1.00 | infobox |
| Pramipexole | CompTox Dashboard (EPA) | DTXSID6023496 | 1.00 | infobox |
| Pramipexole | Drug class | Dopamine receptor agonist; Dopamine D2-like receptor agonist; Antiparkinsonian agent | 1.00 | infobox |
| Pramipexole | DrugBank | DB00413 Y | 1.00 | infobox |
| Pramipexole | ECHA InfoCard | 100.124.761 | 1.00 | infobox |
| Pramipexole | Elimination half-life | 8–12 hours | 1.00 | infobox |
| Pramipexole | Excretion | Urine (90%), feces (2%) | 1.00 | infobox |
| Pramipexole | Formula | C10H17N3S | 1.00 | infobox |
| Pramipexole | IUPHAR/BPS | 953 | 1.00 | infobox |
| Pramipexole | KEGG | D05575 Y | 1.00 | infobox |
| Pramipexole | KEGG | as salt: D00559 Y | 1.00 | infobox |
| Pramipexole | Legal status | BR: Class C1 (Other controlled substances) | 1.00 | infobox |
| Pramipexole | Legal status | CA: ℞-only | 1.00 | infobox |
| Pramipexole | Legal status | US: ℞-only | 1.00 | infobox |
| Pramipexole | Legal status | EU: Rx-only | 1.00 | infobox |
| Pramipexole | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Pramipexole | License data | US DailyMed: Pramipexole | 1.00 | infobox |
| Pramipexole | MedlinePlus | a697029 | 1.00 | infobox |
| Pramipexole | Molar mass | 211.33 g·mol−1 | 1.00 | infobox |
| Pramipexole | PDB ligand | G6L (PDBe, RCSB PDB) | 1.00 | infobox |
| Pramipexole | Pregnancy category | AU: B3 | 1.00 | infobox |
| Pramipexole | Pronunciation | /ˌpræmɪˈpɛksoʊl/ | 1.00 | infobox |
| Pramipexole | Protein binding | 15% | 1.00 | infobox |
The concept neighborhoods around Pramipexole bring nearby vocabulary together. In this analysis, examples include Dopamine, Also and Used. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Pramipexole, one of the stronger structural bridges in this analysis connects Pramipexole with Research. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Pramipexole to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as Applications & Research, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Pramipexole · EN edition · Analysis: TopicsToTalkAbout